Error: Could not add to watchlist. X
+ Watchlist

UBS Lux Equity Fund - Biotech USD

UBSEBIO:LX
624.22
USD
12.56
2.05%
As of 6/20/2018
Fund Type
FCP
52Wk Range
535.61 - 649.68
1 Yr Return
5.31%
YTD Return
5.72%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
611.66
52Wk Range
535.61 - 649.68
1 Yr Return
10.91%
YTD Return
5.72%
Fund Type
FCP
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 06/20/2018)
624.22
Total Assets (b USD) (on 06/20/2018)
1.155
Inception Date
10/15/1996
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
NATHALIE LOTSCHER PETRUS / MATT KONOSKY
Front Load Fee
3.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.63%
Expense Ratio
2.11%

Top Fund Holdings

Name Position Value % of Fund
883.00 k 99.09 m 8.05
1.16 m 97.44 m 7.92
470.89 k 78.58 m 6.39
406.65 k 75.66 m 6.15
602.23 k 71.86 m 5.84
685.05 k 69.30 m 5.63
600.58 k 54.19 m 4.40
127.21 k 44.24 m 3.60
339.25 k 44.10 m 3.58
681.29 k 38.95 m 3.17
Profile
UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.
Address
UBS Equity Fund Management Company
33A avenue J.F. Kennedy
L-1855 Luxembourg
Luxembourg
Phone
352-44-10-10-1 Tel